Global Epinephrine Injection Market Insights and Forecast to 2028

Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
Market Analysis and Insights: Global Epinephrine Injection Market
The global Epinephrine Injection market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Epinephrine Auto-injector accounting for % of the Epinephrine Injection global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Anaphylaxis segment is altered to an % CAGR throughout this forecast period.
China Epinephrine Injection market size is valued at US$ million in 2021, while the North America and Europe Epinephrine Injection are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Epinephrine Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epinephrine Injection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epinephrine Injection market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epinephrine Injection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epinephrine Injection market.
Global Epinephrine Injection Scope and Market Size
Epinephrine Injection market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Epinephrine Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Segment by Application
Anaphylaxis
Cardiac Arrest
Others
By Company
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Frequently Asked Questions